U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Safety
  3. Recalls, Market Withdrawals, & Safety Alerts
  4. FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical Issues Voluntary Nationwide Recall of All Sterile Drug Products Within Expiry Due to A Lack of Assurance of Sterility
  1. Recalls, Market Withdrawals, & Safety Alerts

COMPANY ANNOUNCEMENT

FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical Issues Voluntary Nationwide Recall of All Sterile Drug Products Within Expiry Due to A Lack of Assurance of Sterility

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement

Summary

Company Announcement Date:
FDA Publish Date:
Product Type:
Drugs
Reason for Announcement:
Recall Reason Description
Lack of Assurance of Sterility
Company Name:
FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutcal
Brand Name:
Brand Name(s)
AXIA Pharmaceutical
Product Description:
Product Description
Sterile Drug Products

Company Announcement

FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical is voluntarily recalling all unused sterile drug products within expiry, to the user level, due to a lack of assurance of sterility. The recalled sterile products have been found to be inconsistent with federal guidelines.

Administration of a drug product intended to be sterile that is not sterile could result in serious infections which may be life-threatening. To date, FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical has not received any reports of adverse events related to this recall and is recalling all sterile products out of an abundance of caution and to promote patient safety, which is AXIA pharmaceutical’s highest priority.

For a full listing of the products, including lot numbers and expiration dates, being recalled, please follow this link: http://www.axiapharma.net/recalls.html. Sterile drug product was distributed nationwide to consumers.

FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical is notifying its customers by letter and direct outreach. FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical is arranging for the return of all recalled products. Customers that have any recalled products should stop using and return to FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical.

Consumers with questions regarding this recall can contact FUSION IV Pharmaceuticals, Inc dba. AXIA Pharmaceutical Erdwin Orellana by phone number: (877-685-8222) or e-mail address ecallassistance@axiapharma.net, Monday through Friday: 8:00 AM to 4:00 PM PST.  Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Link to Product List

Company Contact Information

Consumers:
Erdwin Orellana
1 (877) 685-8222
recallassistance@axiapharma.net
Back to Top